Dr. Lal PathLabs Limited
LALPATHLAB
Peringkat dalam Saham
#4524
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Harga Saham
$20.35
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$3.40B
Perubahan (1 hari)
-0.86%
Perubahan (1 tahun)
13.63%
Negara
IN
Perdagangan Dr. Lal PathLabs Limited (LALPATHLAB)
Kategori
Healthcare
Jumlah saham beredar untuk Dr. Lal PathLabs Limited (LALPATHLAB)
Jumlah saham beredar per June 2026: 167.00M
Menurut laporan keuangan terbaru dan harga saham Dr. Lal PathLabs Limited, jumlah saham beredar saat ini adalah 167.00M. Pada akhir March 2024, perusahaan memiliki 166.47M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Dr. Lal PathLabs Limited (LALPATHLAB) dari 2011 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 167.00M | 0.10% |
| 2025 | 166.83M | 0.22% |
| 2024 | 166.47M | 0.15% |
| 2023 | 166.21M | 0.19% |
| 2022 | 165.90M | 0.27% |
| 2021 | 165.46M | 0.22% |
| 2020 | 165.10M | 0.09% |
| 2019 | 164.95M | 0.58% |
| 2018 | 164.01M | 0.52% |
| 2017 | 163.15M | -1.38% |
| 2016 | 165.44M | 0.73% |
| 2015 | 164.24M | 0.00% |
| 2014 | 164.24M | 6.99% |
| 2013 | 153.51M | -7.13% |
| 2012 | 165.29M | 0.00% |
| 2011 | 165.29M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 371.00M | 122.16% |
US
|
|
| 705.30M | 322.35% |
US
|
|
| 143.28M | -14.20% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 68.87% |
US
|
